Altered drug metabolism in parasitic diseases
Identifieur interne : 003223 ( Main/Exploration ); précédent : 003222; suivant : 003224Altered drug metabolism in parasitic diseases
Auteurs : B. L. Tekwanl [Inde] ; O. P. Shukla [Inde] ; S. Ghatak [Inde]Source :
- Parasitology Today [ 0169-4758 ] ; 1988.
English descriptors
- Teeft :
- Active compounds, Active substances, Aniline hydroxylase, Antimalarial drugs, Cerebral tissues, Chloroquine, Corresponding decrease, Cytochrome, Cytochrome reductase, Cytochrome reductase activity, Drug metabolism, Drugmetabolizing enzymes, Endoplasmic reticulum, Falciparum, Falciparum malaria, Fascioliasis, Function oxidase system, Functional group, Hepatic, Hepatic amoebiasis, Hepatica, Hepatica infection, Hepatocellular proliferation, Hexobarbital metabolism, Hexobarbital oxidase, Hydroxylase, Impairment, Infection, Lesser extent, Lipid bilayer, Liver pathology, Main line, Malaria, Metabolism, Microsomal, Microsomal cytochrome, Microsomal membranes, Parasite, Parasitic, Parasitic infection, Parasitic infections, Parasitology today, Patent phase, Pharmacol, Reductase, Schistosomiasis, Severe falciparum malaria, Target molecule, Uncomplicated malaria, Zoxazolamine hydroxylase.
Abstract
Abstract: While the immune system represents the main line of host defence against parasite infections, mixed function oxidase (MFO) systems (Box 1) offer the main line of defence against drugs and other biologically active substances. But, as this review shows, many parasites can exert a profound effect on the host MFO system by altering the microsomal drug-metabolizing enzymes and electron transport carriers such as cytochrome P-450. This can markedly affect the host's ability to metabolize biologically active compounds, often with adverse physiological, pharmacological and toxicological consequences.In mammals, drug metabolism occurs predominantly in the liver, and to a lesser extent in the spleen, lungs, kidneys, intestine and cerebral tissues. Thus those parasites that occupy sites in these tissues - such as amoebae, Fasciola, schistosomes and malaria - tend to be those with greatest effects on the host's ability to metabolize drugs. The effects can modify the host response to substances unrelated to the infection, and to drugs which may be administered under a chemotherapeutic regime.
Url:
DOI: 10.1016/0169-4758(88)90047-6
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001204
- to stream Istex, to step Curation: 001204
- to stream Istex, to step Checkpoint: 001F85
- to stream Main, to step Merge: 003294
- to stream Main, to step Curation: 003223
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Altered drug metabolism in parasitic diseases</title><author><name sortKey="Tekwanl, B L" sort="Tekwanl, B L" uniqKey="Tekwanl B" first="B. L." last="Tekwanl">B. L. Tekwanl</name></author><author><name sortKey="Shukla, O P" sort="Shukla, O P" uniqKey="Shukla O" first="O. P." last="Shukla">O. P. Shukla</name></author><author><name sortKey="Ghatak, S" sort="Ghatak, S" uniqKey="Ghatak S" first="S." last="Ghatak">S. Ghatak</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:194DAD98705CAD7DDBB61EF324503833A8EC6F59</idno><date when="1988" year="1988">1988</date><idno type="doi">10.1016/0169-4758(88)90047-6</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-KVCX4W2B-P/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001204</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001204</idno><idno type="wicri:Area/Istex/Curation">001204</idno><idno type="wicri:Area/Istex/Checkpoint">001F85</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F85</idno><idno type="wicri:doubleKey">0169-4758:1988:Tekwanl B:altered:drug:metabolism</idno><idno type="wicri:Area/Main/Merge">003294</idno><idno type="wicri:Area/Main/Curation">003223</idno><idno type="wicri:Area/Main/Exploration">003223</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Altered drug metabolism in parasitic diseases</title><author><name sortKey="Tekwanl, B L" sort="Tekwanl, B L" uniqKey="Tekwanl B" first="B. L." last="Tekwanl">B. L. Tekwanl</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Laboratory of Parasite Biochemistry, Division of Biochemistry, Central Drug Research Institute, Lucknow-226 001</wicri:regionArea><wicri:noRegion>Lucknow-226 001</wicri:noRegion></affiliation></author><author><name sortKey="Shukla, O P" sort="Shukla, O P" uniqKey="Shukla O" first="O. P." last="Shukla">O. P. Shukla</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Laboratory of Parasite Biochemistry, Division of Biochemistry, Central Drug Research Institute, Lucknow-226 001</wicri:regionArea><wicri:noRegion>Lucknow-226 001</wicri:noRegion></affiliation></author><author><name sortKey="Ghatak, S" sort="Ghatak, S" uniqKey="Ghatak S" first="S." last="Ghatak">S. Ghatak</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Laboratory of Parasite Biochemistry, Division of Biochemistry, Central Drug Research Institute, Lucknow-226 001</wicri:regionArea><wicri:noRegion>Lucknow-226 001</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Parasitology Today</title><title level="j" type="abbrev">PARTOD</title><idno type="ISSN">0169-4758</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1988">1988</date><biblScope unit="volume">4</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="4">4</biblScope><biblScope unit="page" to="10">10</biblScope></imprint><idno type="ISSN">0169-4758</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0169-4758</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Active compounds</term><term>Active substances</term><term>Aniline hydroxylase</term><term>Antimalarial drugs</term><term>Cerebral tissues</term><term>Chloroquine</term><term>Corresponding decrease</term><term>Cytochrome</term><term>Cytochrome reductase</term><term>Cytochrome reductase activity</term><term>Drug metabolism</term><term>Drugmetabolizing enzymes</term><term>Endoplasmic reticulum</term><term>Falciparum</term><term>Falciparum malaria</term><term>Fascioliasis</term><term>Function oxidase system</term><term>Functional group</term><term>Hepatic</term><term>Hepatic amoebiasis</term><term>Hepatica</term><term>Hepatica infection</term><term>Hepatocellular proliferation</term><term>Hexobarbital metabolism</term><term>Hexobarbital oxidase</term><term>Hydroxylase</term><term>Impairment</term><term>Infection</term><term>Lesser extent</term><term>Lipid bilayer</term><term>Liver pathology</term><term>Main line</term><term>Malaria</term><term>Metabolism</term><term>Microsomal</term><term>Microsomal cytochrome</term><term>Microsomal membranes</term><term>Parasite</term><term>Parasitic</term><term>Parasitic infection</term><term>Parasitic infections</term><term>Parasitology today</term><term>Patent phase</term><term>Pharmacol</term><term>Reductase</term><term>Schistosomiasis</term><term>Severe falciparum malaria</term><term>Target molecule</term><term>Uncomplicated malaria</term><term>Zoxazolamine hydroxylase</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: While the immune system represents the main line of host defence against parasite infections, mixed function oxidase (MFO) systems (Box 1) offer the main line of defence against drugs and other biologically active substances. But, as this review shows, many parasites can exert a profound effect on the host MFO system by altering the microsomal drug-metabolizing enzymes and electron transport carriers such as cytochrome P-450. This can markedly affect the host's ability to metabolize biologically active compounds, often with adverse physiological, pharmacological and toxicological consequences.In mammals, drug metabolism occurs predominantly in the liver, and to a lesser extent in the spleen, lungs, kidneys, intestine and cerebral tissues. Thus those parasites that occupy sites in these tissues - such as amoebae, Fasciola, schistosomes and malaria - tend to be those with greatest effects on the host's ability to metabolize drugs. The effects can modify the host response to substances unrelated to the infection, and to drugs which may be administered under a chemotherapeutic regime.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><country name="Inde"><noRegion><name sortKey="Tekwanl, B L" sort="Tekwanl, B L" uniqKey="Tekwanl B" first="B. L." last="Tekwanl">B. L. Tekwanl</name></noRegion><name sortKey="Ghatak, S" sort="Ghatak, S" uniqKey="Ghatak S" first="S." last="Ghatak">S. Ghatak</name><name sortKey="Shukla, O P" sort="Shukla, O P" uniqKey="Shukla O" first="O. P." last="Shukla">O. P. Shukla</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003223 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003223 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:194DAD98705CAD7DDBB61EF324503833A8EC6F59
|texte= Altered drug metabolism in parasitic diseases
}}
| This area was generated with Dilib version V0.6.33. |  |